Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Vivitrex

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,922Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Currax to Offer CONTRAVE Free to Federal Staff During Shutdown
    Currax to Offer CONTRAVE Free to Federal Staff During Shutdown

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-llc-to-provide-contrave-at-no-cost-to-federal-employees-during-government-shutdown-302592592.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Alkermes Faces Lawsuit For Blocking Generic Vivitrol
    Alkermes Faces Lawsuit For Blocking Generic Vivitrol

    03 Oct 2025

    // REUTERS

    https://www.reuters.com/legal/government/alkermes-sued-over-alleged-scheme-block-generic-vivitrol-2025-10-03/

    REUTERS
    03 Oct 2025
    Share Share
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety
    Currax Study In Obesity Pillars Supports CONTRAVE/MYSIMBA CV Safety

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/currax-pharmaceuticals-peer-reviewed-study-in-obesity-pillars-further-substantiates-cardiovascular-safety-profile-of-contravemysimba-302397897.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added
    Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added

    27 Jul 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugs-dont-make-whos-essential-list-ebola-ms-drugs-added-2023-07-26/

    REUTERS
    27 Jul 2023
    Share Share
    Teva's Generic Naltrexone Receives Approval in the U.S.
    Teva's Generic Naltrexone Receives Approval in the U.S.

    06 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213195

    FDA
    06 Jul 2023
    Share Share
    JanOne files international patent appl. for methods of using low dose naltrexone
    JanOne files international patent appl. for methods of using low dose naltrexone

    28 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/janone-files-international-patent-application-for-methods-of-using-low-dose-naltrexone-to-treat-chronic-pain-301865422.html

    PR NEWSWIRE
    28 Jun 2023
    Share Share